Under construction – not a live service
Sign in
Taking people in BelgiumNo phase

Checking for Fatty Liver Disease in People With Type 1 Diabetes

Uses a FibroScan liver test in adults with type 1 diabetes.

Plain-language title generated from the registry record
Registry title: Prevalence of NAFLD in T1DM Patients

Key facts

Where
Genk, BelgiumSee the site

Where in Belgium

  • Ziekenhuis Oost-LimburgGenk, BelgiumTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Ziekenhuis Oost-Limburg
Trial code
NCT06445361
Record updated
28 July 2025
Original description
To determine the prevalence of NAFLD in T1DM patients.Read full original descriptionShow less

The Prevalence of Non-Alcoholic Fatty Liver Disease in Type 1 Diabetes Mellitus Patients Followed at Ziekenhuis Oost-Limburg, Genk, Belgium

To determine the prevalence of NAFLD in T1DM patients.

Inclusion: T1DM; ≥ 18 years of age; Written informed consent obtained.

Exclusion: Exclusion of other causes of liver disease and secondary causes of liver steatosis; Excessive alcohol use.

ClinicalTrials.gov NCT06445361